Page last updated: 2024-08-24

sesamol and sb 203580

sesamol has been researched along with sb 203580 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, CM; Chen, CH; Chen, FY; Chen, WY; Hsu, JF; Lee, AS; Lee, WS; Shen, MY; Sheu, JR; Ting, KH	1

Other Studies

1 other study(ies) available for sesamol and sb 203580

Article	Year
Sesamol reduces the atherogenicity of electronegative L5 LDL in vivo and in vitro. Journal of natural products, 2015, Feb-27, Volume: 78, Issue:2 Topics: Animals; Apoptosis; Atherosclerosis; Benzodioxoles; Blotting, Western; Caspase 3; Cricetinae; Dose-Response Relationship, Drug; Endothelial Cells; Humans; In Vitro Techniques; Lipoproteins, LDL; Male; Molecular Structure; Phenols; Scavenger Receptors, Class E	2015

Article

Year

Sesamol reduces the atherogenicity of electronegative L5 LDL in vivo and in vitro.

Journal of natural products, 2015, Feb-27, Volume: 78, Issue:2

Topics: Animals; Apoptosis; Atherosclerosis; Benzodioxoles; Blotting, Western; Caspase 3; Cricetinae; Dose-Response Relationship, Drug; Endothelial Cells; Humans; In Vitro Techniques; Lipoproteins, LDL; Male; Molecular Structure; Phenols; Scavenger Receptors, Class E

2015